These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 31849033)

  • 21. Take -home naloxone rescue kits following heroin overdose in the emergency department to prevent opioid overdose related repeat emergency department visits, hospitalization and death- a pilot study.
    Papp J; Vallabhaneni M; Morales A; Schrock JW
    BMC Health Serv Res; 2019 Dec; 19(1):957. PubMed ID: 31829228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute severe intoxication with cyclopropylfentanyl, a novel synthetic opioid.
    Wilde M; Sommer MJ; Auwärter V; Hermanns-Clausen M
    Toxicol Lett; 2020 Mar; 320():109-112. PubMed ID: 31778775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The dawn of a new synthetic opioid era: the need for innovative interventions.
    Pardo B; Taylor J; Caulkins J; Reuter P; Kilmer B
    Addiction; 2021 Jun; 116(6):1304-1312. PubMed ID: 32869394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fentanyl causes naloxone-resistant vocal cord closure: A platform for testing opioid overdose treatments.
    Miner NB; Schutzer WE; Zarnegarnia Y; Janowsky A; Torralva R
    Drug Alcohol Depend; 2021 Oct; 227():108974. PubMed ID: 34492557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infant and Toddler Ingestion of Illicit Fentanyl: A Case Series.
    Slingsby B; Moore JL; Barron CE
    Clin Pediatr (Phila); 2019 Nov; 58(13):1449-1451. PubMed ID: 31544503
    [No Abstract]   [Full Text] [Related]  

  • 26. Impact of the Opioid Epidemic.
    Lavonas EJ; Dezfulian C
    Crit Care Clin; 2020 Oct; 36(4):753-769. PubMed ID: 32892827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overdoses due to fentanyl and its analogues (F/FAs) push naloxone to the limit.
    Pergolizzi JV; Dahan A; Ann LeQuang J; Raffa RB
    J Clin Pharm Ther; 2021 Dec; 46(6):1501-1504. PubMed ID: 34111307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naloxone dosing in the era of ultra-potent opioid overdoses: a systematic review.
    Moe J; Godwin J; Purssell R; O'Sullivan F; Hau JP; Purssell E; Curran J; Doyle-Waters MM; Brasher PMA; Buxton JA; Hohl CM
    CJEM; 2020 Mar; 22(2):178-186. PubMed ID: 31955714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological Profiling of Antifentanyl Monoclonal Antibodies in Combination with Naloxone in Pre- and Postexposure Models of Fentanyl Toxicity.
    Baehr CA; Wu MM; Pandit SG; Arias-Umana J; AuCoin D; Pravetoni M
    J Pharmacol Exp Ther; 2022 May; 381(2):129-136. PubMed ID: 35153198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urban, individuals of color are impacted by fentanyl-contaminated heroin.
    Rhodes B; Costenbader B; Wilson L; Hershow R; Carroll J; Zule W; Golin C; Brinkley-Rubinstein L
    Int J Drug Policy; 2019 Nov; 73():1-6. PubMed ID: 31330274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlates of seeking emergency medical help in the event of an overdose in British Columbia, Canada: Findings from the Take Home Naloxone program.
    Karamouzian M; Kuo M; Crabtree A; Buxton JA
    Int J Drug Policy; 2019 Sep; 71():157-163. PubMed ID: 30691944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Fentanyl Test Strip Use, Perceived Overdose Risk, and Naloxone Possession among People Who Use Drugs.
    Tilhou AS; Zaborek J; Baltes A; Salisbury-Afshar E; Malicki J; Brown R
    Subst Use Misuse; 2024; 59(2):254-257. PubMed ID: 37807227
    [No Abstract]   [Full Text] [Related]  

  • 33. Ventilatory Effects of Fentanyl, Heroin, and
    Hiranita T; Ho NP; France CP
    J Pharmacol Exp Ther; 2024 Jan; 388(2):244-256. PubMed ID: 37739803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unintentional overdoses: understanding the fentanyl landscape and reducing harm.
    Bell LA; Hadland SE
    Curr Opin Pediatr; 2023 Aug; 35(4):408-414. PubMed ID: 36974444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engagement in Harm Reduction Strategies After Suspected Fentanyl Contamination Among Opioid-Dependent Individuals.
    Mistler CB; Chandra DK; Copenhaver MM; Wickersham JA; Shrestha R
    J Community Health; 2021 Apr; 46(2):349-357. PubMed ID: 32997253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies.
    Han Y; Yan W; Zheng Y; Khan MZ; Yuan K; Lu L
    Transl Psychiatry; 2019 Nov; 9(1):282. PubMed ID: 31712552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose naloxone formulations are not as essential as we thought.
    Lemen PM; Garrett DP; Thompson E; Aho M; Vasquez C; Park JN
    Harm Reduct J; 2024 May; 21(1):93. PubMed ID: 38741224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fentanyl and fentanyl-analog involvement in drug-related deaths.
    Dai Z; Abate MA; Smith GS; Kraner JC; Mock AR
    Drug Alcohol Depend; 2019 Mar; 196():1-8. PubMed ID: 30658219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-Medical Use of Novel Synthetic Opioids: A New Challenge to Public Health.
    Lovrecic B; Lovrecic M; Gabrovec B; Carli M; Pacini M; Maremmani AGI; Maremmani I
    Int J Environ Res Public Health; 2019 Jan; 16(2):. PubMed ID: 30634521
    [No Abstract]   [Full Text] [Related]  

  • 40. High concentrations of illicit stimulants and cutting agents cause false positives on fentanyl test strips.
    Lockwood TE; Vervoordt A; Lieberman M
    Harm Reduct J; 2021 Mar; 18(1):30. PubMed ID: 33750405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.